Department | Course Name / Course Code | Course Code |
---|
Associate Professor
Medicinal Chemistry
9810928555
rakesh[dot]singh[at]niperrbl[dot]ac[dot]in
Translational studies on the molecular inflammatory pathways involved in chronic neurodegenerative diseases by both in-vitro and in-vivo approach.
India , Assam
India , Punjab
India ,
IL-17 A Exacerbated Neuroinflammatory and Neurodegenerative Biomarkers in Intranasal Amyloid-Beta Model of Alzheimer’s Disease
/ Publisher Name: Springer / Journal Name: "Journal of Neuroimmune Pharmacology" / Volume Number: 20 / Publish Date Online: 2025-03-31 / Research Article / 2025 / Impact Factor: 5.2 / Accepted Web Link DOIIntranasal amyloid model of Alzheimer’s disease - potential opportunities and challenges
/ Publisher Name: Springer / Journal Name: "Pharmacological Reports" / Volume Number: 77 / Publish Date Online: 2025-01-08 / Research Article / 2025 / Impact Factor: 3.6 / Accepted Web Link DOITherapeutic potential of chrysin in regulation of interleukin-17 signaling in a repeated intranasal amyloid-beta-induced Alzheimer's disease model
/ Publisher Name: Royal Society of Chemistry / Journal Name: "Food and Function" / Volume Number: 16 / Publish Date Online: 2024-12-17 / Research Article / 2024 / Impact Factor: 5.1 / Accepted Web Link DOIIL-17A-Induced Redox Imbalance and Inflammatory Responses in Mice Lung via Act1-TRAF6-IKBα Signaling Pathway: Implications for Lung Disease Pathogenesis
/ Publisher Name: Springer / Journal Name: "Inflammation" / Publish Date Online: 2024-11-28 / Research Article / 2024 / Impact Factor: 4.5 / Accepted Web Link DOIIdentifying interventions that improve medication safety & rational use of medicines in India
/ Publisher Name: Medknow Publishers / Journal Name: "The Indian Journal of Medical Research" / Volume Number: 159 / Publish Date Online: 2024-08-03 / Research Article / 2024 / Impact Factor: 2.7 / Accepted Web Link DOIQuercetin ameliorates neuroinflammatory and neurodegenerative biomarkers in the brain and improves neurobehavioral parameters in a repeated intranasal amyloid-beta exposed model of Alzheimer's disease
/ Publisher Name: Royal Society of Chemistry / Journal Name: "Food and Function" / Volume Number: 16 / Publish Date Online: 2024-07-19 / Research Article / 2024 / Impact Factor: 5.1 / Accepted Web Link DOIMK2 inhibitor PF‐3644022 shows protective effect in mouse microglial N9 cell line induced with cigarette smoke extract
/ Publisher Name: Wiley / Journal Name: "Chemical Biology and Drug Design" / Volume Number: 104 / Publish Date Online: 2024-07-16 / Research Article / 2024 / Impact Factor: 3.2 / Accepted Web Link DOIToxicity Study of 3-Thienylalanine-Ornithine-Proline (TOP) Using as Novel ACE Inhibitor
/ Publisher Name: SPringer / Journal Name: "International Journal of Peptide Research and Therapeutics" / Volume Number: 28 / Publish Date Online: 2022-09-03 / Research Article / 2022 / Impact Factor: 2 / Accepted Web Link DOIThe clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis
/ Publisher Name: Springer / Journal Name: "Neurological sciences" / Volume Number: 43 / Publish Date Online: 2022-05-25 / Research Article / 2022 / Impact Factor: 2.7 / Accepted Web Link DOIIron‐induced cellular in vitro neurotoxic responses in rat C6 cell line
/ Publisher Name: Wiley / Journal Name: "Environmental Toxicology" / Volume Number: 37 / Publish Date Online: 2022-04-21 / Research Article / 2022 / Impact Factor: 4.4 / Accepted Web Link DOIChronic oral exposure of aluminum chloride in rat modulates molecular and functional neurotoxic markers relevant to Alzheimer’s disease
/ Publisher Name: Taylor and Francis / Journal Name: "Toxicology Mechanisms and Methods" / Volume Number: 32 / Publish Date Online: 2022-04-07 / Research Article / 2022 / Impact Factor: 2.8 / Accepted Web Link DOIThe role of RIPK1 in chronic obstructive pulmonary disease
/ Publisher Name: Elsevier / Journal Name: "Drug Discovery Today" / Volume Number: 29 / Publish Date Online: 2024-05-18 / Review Article / 2024 / Impact Factor: 6.5 / Accepted Web Link DOIRecent developments in nucleic acid-based therapies for Parkinson’s disease: current status, clinical potential, and future strategies
/ Publisher Name: Frontiers Publishers / Journal Name: "Frontiers in Pharmacology" / Volume Number: 13 / Publish Date Online: 2022-10-20 / Review Article / 2022 / Impact Factor: 4.4 / Accepted Web Link DOINeurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer’s disease
/ Publisher Name: Springer / Journal Name: "Pharmacological Reports" / Volume Number: 74 / Publish Date Online: 2022-01-27 / Review Article / 2022 / Impact Factor: 3.6 / Accepted Web Link DOIRole of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
/ Publisher Name: Wiley / Journal Name: "Journal of Medical Virology" / Volume Number: 94 / Publish Date Online: 2021-10-21 / Review Article / 2021 / Impact Factor: 6.8 / Accepted Web Link DOISynthesis and Evaluation of Nitrogen Tethered Derivatives in Cell-Based and Animal Models of Acute Lung Injury
UPCST | NIPER Raebareli | 1530000 | 25 Nov 2024 - 24 Nov 2027 |
Design, Synthesis, Characterization of Dibromo Indolizine analogs and Evaluation of their Anti-inflammatory Activity in vitro
Uttar Pradesh COuncil of Science and Technology (UPCST), Lucknow, India, | NIPER Raebareli | 900000 | 01 Mar 2024 - 28 Feb 2026 |
Dose-dependent effect of IL-17 induced lung inflammation in mice model
National Institute of Pharmaceutical Education and Research, Raebareli | NIPER Raebareli | 01 Aug 2023 - 28 Jun 2024 |
Effect of cigarette smoke extract on biomarkers of neuro-inflammation and oxidative stress in cell line.
National Institute of Pharmaceutical Education and Research, Raebareli | NIPER Raebareli | 01 Aug 2022 - 30 Jun 2023 |
Role of TLR4-p38MAPK-MK2 axis in amyloid beta-induced in-vitro and in-vivo model
National Institute of Pharmaceutical Education and Research, Raebareli | NIPER Raebareli | 01 Aug 2022 - 30 Jun 2023 |
Protective effect of NRF2 activator in allergens-induced lung inflammation.
National Institute of Pharmaceutical Education and Research, Raebareli | NIPER Raebareli | 01 Aug 2022 - 30 Jun 2023 |
Evaluation of RIPK1-induced Disease-associated Microglia response.
National Institute of Pharmaceutical Education and Research, Raebareli | NIPER Raebareli | 01 Aug 2022 - 30 Jun 2023 |
Scholar Name | Research Interest | University Name | Date of Registration | Award Date | Submitted Date | Status |
---|